The article has been reviewed for time-sensitive claims. We’ve confirmed the key data points are current or properly framed as historical as of today, Tuesday, November 10, 2026. The 156% rise in patient payments at the Neurological Center of New England, cited by eClinicalWorks, is a “2025 customer result” from their website which matches May 2025 press releases about Q1 2024 data. iRhythm Technologies is still a clear leader in ambulatory cardiac monitoring, especially for long-term continuous use. The current version of NIST SP 800-66r2 was finalized in February 2024. No corrections are needed. Digital payment vendors love throwing around big numbers to sell you on a better revenue cycle. For the people actually running specialty practices and managing revenue, these claims need a closer look. When eClinicalWorks says the Neurological Center of New England boosted patient payments by over 156% with its tools, a 2025 customer result from its own site, it’s an impressive but totally opaque figure. A jump like that means one of two things: the tools are incredibly effective, or the practice’s collections were abysmal to begin with. The case study page doesn’t give you the context to know which it is. So what does a 156% jump in patient payments actually tell you about a practice’s RCM automation? We’re going to pick that claim apart. We’ll use the concepts of a Vertical AI approach and EHR Interoperability work, holding up iRhythm Technologies as an example of the complex payment path a specialty program has to follow when billing and clinical records are properly connected. The real question for anyone looking to buy this tech is what’s not being said, what are the hidden costs in workflow changes and claim rework that don’t show up in a headline number?
The Allure and Ambiguity of the 156% Claim
Sure, a 156% pop in patient payments looks great. For any specialty practice watching patient responsibility creep up, that number suggests a huge financial turnaround. eClinicalWorks points to this 2025 customer result as a direct win for their digital payment tools. But with no baseline figure for what the practice was collecting before, there’s a massive data gap. Was the Neurological Center of New England starting with terrible collections, making any small improvement look huge? Or did the tools really supercharge an already decent system? Without the denominator, the percentage is a powerful marketing tool, not a quantifiable metric of success. Plus, the claim doesn’t separate more payments from faster payments. Both help the P&L, but they mean very different things for your staff’s workload and how happy your patients are. Faster money frees up capital, obviously. But a higher volume of collected payments, a much more difficult achievement, could mean the tool is actually getting patients to engage and pay bills they would have otherwise ignored. The vendor’s page doesn’t say which it was.
Working through the Specialty Payment Path with Vertical AI
A specialty practice’s revenue cycle isn’t just a simple credit card swipe. It’s a whole journey starting from the moment a patient walks in, winding through documentation, coding, claims, and finally, getting paid. That path gets really tricky in specialties like cardiology, diabetes, behavioral health, and oncology, where the diagnoses and treatments require deep clinical knowledge to code and bill correctly. And that’s the whole point of vertical AI healthcare companies versus some generic, one-size-fits-all platforms. Look at a company like iRhythm Technologies, a leader in cardiac monitoring. Their Vertical AI approach for detecting arrhythmias is built for deep EHR Interoperability. This means their AI algorithms talk directly to existing electronic health record systems. When a cardiologist puts iRhythm’s Zio XT patch on a patient, the data gathered and sorted by their AI flows straight into the clinical record, which is exactly how it should work. That integration goes all the way to the revenue cycle. The super-specific diagnostic codes that a disease-specific AI health platform like iRhythm’s generates are what you need for a clean claim submission. Your billing automation has to follow that same path, because in a well-run practice, the clinical data is the financial data. A generic payment tool, by contrast, might give you a slick interface for collecting copays, but it has zero understanding of specialty coding and isn’t deeply integrated with the clinical side. A behavioral health specialization AI tool, for instance, would already know the specific billing codes and documentation rules for different therapy sessions, resulting in fewer denials than a generic system that treats every visit the same. This kind of vertical focus isn’t just a feature set. It’s baked-in intelligence that gets the specific clinical and administrative workflows of a medical specialty.
What the Record Leaves Unpriced and Unseen
If you’re a practice administrator or RCM lead, you have to do a full cost-benefit analysis before buying any new payment tool. That 156% number is great, but it’s only half the story. What the eClinicalWorks claim doesn’t tell you, the stuff you need to know for a real evaluation, are the hidden costs:
- Staff Time on New Workflow: Any new tech means training. How much time will your staff actually spend learning and using these tools? Does it add clicks or actually reduce their admin load? The time you “save” with automation can get eaten up fast by the time spent managing another new system. Case study on workflow impact of new EHR features
- Claim Rework and Denial Rates: Vendors pitch these tools as a way to cut denials. But a generic tool that doesn’t get specialty coding can just create new kinds of errors and more rework. A system that’s actually optimized, like what you see with iRhythm’s EHR interoperability efforts, should be able to show you a measurable drop in denial rates because it bakes in accuracy from the start.
- The Undisclosed Baseline: Like we said, without knowing the collections baseline, that 156% figure is mostly noise. Were they starting from almost nothing, or did they just juice an already decent collection rate? That context changes everything.
- Hidden Costs of Integration: Vendors promise easy integration, but it’s rarely that simple. Connecting to your EHR and PM systems can bring unexpected IT costs, downtime, and more maintenance headaches. You won’t see those costs in the vendor’s case study.
- Patient Experience and Satisfaction: Getting paid is the goal, but the patient’s experience during that process matters a lot too. Does this new portal make it easier for them to pay, or is it just another password they’ll forget? A smooth payment process can help with patient retention and your practice’s reputation.
The contrast with a company like iRhythm Technologies is stark. Their success is built on a data moat of millions of labeled ECG recordings which gives them highly accurate diagnoses and, therefore, highly accurate billing. Because they are an AI-native company, their product, data pipeline, and business model were all designed around AI from day one, which forces the clinical and administrative processes to be linked and optimized. This integrated model reduces the “unpriced” factors because the AI is built to improve the whole process, from diagnosis all the way to payment.
“For specialty practices, the true value of digital payment tools isn’t a percentage bump in collections. It’s about how smart and smooth the entire payment path is, from clinical documentation to final reconciliation. A generic solution might offer convenience, but a vertically specialized AI system offers precision and embedded expertise.”
What Collections Evidence Would Settle the Case
Specialty practices need proof, not just a percentage, to turn a vendor’s claim into a real result. You need a totally transparent look at how it affects your entire revenue cycle. So when you’re looking at these tools, here’s the evidence you should demand to see what’s really going on:
- Clear Baseline Data: Make the vendor show you independently verifiable baseline numbers for pre-adoption patient payment rates and total revenue. That’s the only way to calculate the
Frequently Asked Questions
Does a 156% increase in patient payments definitively prove the effectiveness of digital payment tools?
No, a 156% increase in patient payments does not definitively prove the effectiveness of digital payment tools on its own. The article states that this substantial increase invites two immediate interpretations: either the tools are profoundly effective, or the starting point for collections was remarkably low. Without knowing the baseline figure for pre-adoption patient payments, the percentage is a powerful but unquantifiable metric of success.
Does a reported payment increase differentiate between more payments and faster payments?
The article indicates that the reported payment increase does not differentiate between more payments and faster payments. Both contribute to a healthier revenue cycle, but their implications for operational efficiency and patient satisfaction differ. The recorded information does not clarify which aspect of payment collection was primarily impacted.
How do specialty-specific AI tools differ from general-purpose digital payment tools in optimizing the revenue cycle?
Specialty-specific AI tools, like those with a Vertical AI approach, are deeply integrated with EHR Interoperability and possess inherent understanding of specialty-specific coding nuances. They can generate precise diagnostic codes crucial for accurate claims submission, leading to fewer claim denials and rework. In contrast, general-purpose digital payment tools may streamline collection but lack the deep integration and embedded intelligence for specific clinical and administrative workflows of a given medical specialty.